Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab′)₂ fragment of anti-CD16 antibody

By Jewett Anahid   Teruel Antonia   Romero Marcela   Head Christian   Cacalano Nicholas  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 7, 2008-07 ,pp. : 1053-1066

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors

By Macaulay V. M.   Middleton M. R.   Protheroe A. S.   Tolcher A.   Dieras V.   Sessa C.   Bahleda R.   Blay J.-Y.   LoRusso P.   Mery-Mignard D.   Soria J.-C.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 784-791

Oxford University Press

Access to resources Recommend Favorite

Radioimmunotherapy of DU-145 Tumours in Nude Mice: A Pilot Study with E4, A Novel Monoclonal Antibody Against Prostate Cancer

By Rydh Anders   Riklund-Åhlström Katrine   Widmark Anders   Bergh Anders   Johansson Lennart   Tavelin Björn   Nilsson Sten   Stigbrand Torgny   Damber Jan-Erik   Hietala Sven-Ola  

Acta Oncologica, Vol. 38, Iss. 8, 1999-12 ,pp. : 1075-1079

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal antibody to human trk-A: diagnostic and therapeutic potential in neuroblastoma

By Kramer K.   Gerald W.   LeSauteur L.   Saragovi H.U.   Cheung N.-K.V.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2090-2091

Elsevier

Access to resources Recommend Favorite

A phase I dose-escalation study to a predefined dose of a transforming growth factor-β1 monoclonal antibody (TβM1) in patients with metastatic cancer

By  

International Journal of Oncology, Vol. 45, Iss. 6, 2014-01 ,pp. : 2221-2231

Spandidos Publications

Access to resources Recommend Favorite